Cargando…
Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
Cholinesterase inhibitors are frequently used to treat cognitive symptoms in Lewy body dementias (Parkinson’s disease dementia and dementia with Lewy bodies). However, the selectivity of their effects remains unclear. In a novel rivastigmine withdrawal design, Parkinson’s disease dementia and dement...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404008/ https://www.ncbi.nlm.nih.gov/pubmed/37545547 http://dx.doi.org/10.1093/braincomms/fcad207 |
_version_ | 1785085200998334464 |
---|---|
author | Fallon, Sean James Plant, Olivia Tabi, Younes A Manohar, Sanjay G Husain, Masud |
author_facet | Fallon, Sean James Plant, Olivia Tabi, Younes A Manohar, Sanjay G Husain, Masud |
author_sort | Fallon, Sean James |
collection | PubMed |
description | Cholinesterase inhibitors are frequently used to treat cognitive symptoms in Lewy body dementias (Parkinson’s disease dementia and dementia with Lewy bodies). However, the selectivity of their effects remains unclear. In a novel rivastigmine withdrawal design, Parkinson’s disease dementia and dementia with Lewy bodies patients were tested twice: once when taking rivastigmine as usual and once when they had missed one dose. In each session, they performed a suite of tasks (sustained attention, simple short-term recall, distractor resistance and manipulating the focus of attention) that allowed us to investigate the cognitive mechanisms through which rivastigmine affects attentional control. Consistent with previous literature, rivastigmine withdrawal significantly impaired attentional efficacy (quicker response latencies without a change in accuracy). However, it had no effects on cognitive control as assessed by the ability to withhold a response (inhibitory control). Worse short-term memory performance was also observed when patients were OFF rivastigmine, but these effects were delay and load independent, likely due to impaired visual attention. In contrast to previous studies that have examined the effects of dopamine withdrawal, cognitively complex tasks requiring control over the contents of working memory (ignoring, updating or shifting the focus of attention) were not significantly impaired by rivastigmine withdrawal. Cumulatively, these data support that the conclusion that cholinesterase inhibition has relatively specific and circumscribed—rather than global—effects on attention that may also affect performance on simple short-term memory tasks, but not when cognitive control over working memory is required. The results also indicate that the withdrawal of a single dose of rivastigmine is sufficient to reveal these impairments, demonstrating that cholinergic withdrawal can be an informative clinical as well as an investigative tool. |
format | Online Article Text |
id | pubmed-10404008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104040082023-08-06 Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias Fallon, Sean James Plant, Olivia Tabi, Younes A Manohar, Sanjay G Husain, Masud Brain Commun Original Article Cholinesterase inhibitors are frequently used to treat cognitive symptoms in Lewy body dementias (Parkinson’s disease dementia and dementia with Lewy bodies). However, the selectivity of their effects remains unclear. In a novel rivastigmine withdrawal design, Parkinson’s disease dementia and dementia with Lewy bodies patients were tested twice: once when taking rivastigmine as usual and once when they had missed one dose. In each session, they performed a suite of tasks (sustained attention, simple short-term recall, distractor resistance and manipulating the focus of attention) that allowed us to investigate the cognitive mechanisms through which rivastigmine affects attentional control. Consistent with previous literature, rivastigmine withdrawal significantly impaired attentional efficacy (quicker response latencies without a change in accuracy). However, it had no effects on cognitive control as assessed by the ability to withhold a response (inhibitory control). Worse short-term memory performance was also observed when patients were OFF rivastigmine, but these effects were delay and load independent, likely due to impaired visual attention. In contrast to previous studies that have examined the effects of dopamine withdrawal, cognitively complex tasks requiring control over the contents of working memory (ignoring, updating or shifting the focus of attention) were not significantly impaired by rivastigmine withdrawal. Cumulatively, these data support that the conclusion that cholinesterase inhibition has relatively specific and circumscribed—rather than global—effects on attention that may also affect performance on simple short-term memory tasks, but not when cognitive control over working memory is required. The results also indicate that the withdrawal of a single dose of rivastigmine is sufficient to reveal these impairments, demonstrating that cholinergic withdrawal can be an informative clinical as well as an investigative tool. Oxford University Press 2023-07-27 /pmc/articles/PMC10404008/ /pubmed/37545547 http://dx.doi.org/10.1093/braincomms/fcad207 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Fallon, Sean James Plant, Olivia Tabi, Younes A Manohar, Sanjay G Husain, Masud Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias |
title | Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias |
title_full | Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias |
title_fullStr | Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias |
title_full_unstemmed | Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias |
title_short | Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias |
title_sort | effects of cholinesterase inhibition on attention and working memory in lewy body dementias |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404008/ https://www.ncbi.nlm.nih.gov/pubmed/37545547 http://dx.doi.org/10.1093/braincomms/fcad207 |
work_keys_str_mv | AT fallonseanjames effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias AT plantolivia effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias AT tabiyounesa effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias AT manoharsanjayg effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias AT husainmasud effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias |